DMAC Latest Press Releases

-- October 22, 2026 --

DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial Business Wire 8:00 AM

-- October 19, 2026 --

DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar Business Wire 8:00 AM

-- September 30, 2026 --

DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results Business Wire 8:30 AM

-- September 2, 2026 --

DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences Business Wire 8:30 AM

-- August 10, 2026 --

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights Business Wire 4:30 PM

-- August 4, 2026 --

DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026 Business Wire 4:30 PM

-- July 17, 2026 --

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- June 23, 2026 --

DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction Business Wire 8:30 AM

-- June 16, 2026 --

DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program Business Wire 8:30 AM

Market Data Delayed 15 Minutes